Stocks and Investing Stocks and Investing
Fri, November 18, 2022
[ 12:00 AM ] - United States, WOPRAI
Jeff Cantwell Maintained (STNE) at Hold with Increased Target to $12 on, Nov 18th, 2022
[ 12:00 AM ] - United States, WOPRAI
Gabriel Moreen Maintained (SR) at Hold with Decreased Target to $72 on, Nov 18th, 2022
[ 12:00 AM ] - United States, WOPRAI
PJ Juvekar Maintained (SQM) at Strong Buy with Decreased Target to $112 on, Nov 18th, 2022
[ 12:00 AM ] - United States, WOPRAI
Corinne Blanchard Maintained (SQM) at Strong Buy with Decreased Target to $125 on, Nov 18th, 2022
[ 12:00 AM ] - United States, WOPRAI
Tessa Romero Maintained (SRRK) at Buy with Decreased Target to $20 on, Nov 18th, 2022
[ 12:00 AM ] - United States, WOPRAI
Yatin Suneja Downgraded (SRZN) to Hold on, Nov 18th, 2022
[ 12:00 AM ] - United States, WOPRAI
David Gagliano Maintained (BTU) at Hold with Increased Target to $31 on, Nov 18th, 2022
Thu, November 17, 2022
[ 12:00 AM ] - United States, WOPRAI
Mark Lear Maintained (STR) at Buy with Increased Target to $35 on, Nov 17th, 2022
[ 12:00 AM ] - United States, WOPRAI
Bradley Thomas Maintained (TGT) at Buy with Decreased Target to $180 on, Nov 17th, 2022
[ 12:00 AM ] - United States, WOPRAI
Joseph Feldman Maintained (TGT) at Buy with Decreased Target to $175 on, Nov 17th, 2022
[ 12:00 AM ] - United States, WOPRAI
Kelly Bania Downgraded (TGT) to Hold and Decreased Target to $165 on, Nov 17th, 2022
[ 12:00 AM ] - United States, WOPRAI
Paul Trussell Downgraded (TGT) to Hold and Decreased Target to $144 on, Nov 17th, 2022
[ 12:00 AM ] - United States, WOPRAI
Edward Yruma Upgraded (TGT) to Buy and Increased Target to $200 on, Nov 17th, 2022
[ 12:00 AM ] - United States, WOPRAI
Paul Lejuez Maintained (TGT) at Strong Buy with Decreased Target to $177 on, Nov 17th, 2022
[ 12:00 AM ] - United States, WOPRAI
Michael Lasser Maintained (TGT) at Strong Buy with Decreased Target to $194 on, Nov 17th, 2022
[ 12:00 AM ] - United States, WOPRAI
Robert Moskow Maintained (TGT) at Buy with Decreased Target to $165 on, Nov 17th, 2022
[ 12:00 AM ] - United States, WOPRAI
Steven Shemesh Maintained (TGT) at Buy with Decreased Target to $206 on, Nov 17th, 2022
[ 12:00 AM ] - United States, WOPRAI
Simon Flannery Initiated (VTYX) at Buy and Held Target at $45 on, Nov 17th, 2022
[ 12:00 AM ] - United States, WOPRAI
Jasper Hellweg Maintained (VRTX) at Strong Buy with Increased Target to $340 on, Nov 17th, 2022
[ 12:00 AM ] - United States, WOPRAI
Rajat Gupta Upgraded (VRM) to Hold on, Nov 17th, 2022
[ 12:00 AM ] - United States, WOPRAI
Brian McNamara Initiated (YETI) at Strong Buy and Held Target at $58 on, Nov 17th, 2022
[ 12:00 AM ] - United States, WOPRAI
Paul Gong Upgraded (XPEV) to Strong Buy and Decreased Target to $13 on, Nov 17th, 2022
[ 12:00 AM ] - United States, WOPRAI
Mark Massaro Maintained (XGN) at Strong Buy with Decreased Target to $7 on, Nov 17th, 2022
[ 12:00 AM ] - United States, WOPRAI
Peter Benedict Maintained (TGT) at Buy with Decreased Target to $180 on, Nov 17th, 2022
[ 12:00 AM ] - United States, WOPRAI
Christopher Horvers Maintained (TGT) at Buy with Decreased Target to $201 on, Nov 17th, 2022
[ 12:00 AM ] - United States, WOPRAI
Bobby Griffin Maintained (TGT) at Strong Buy with Decreased Target to $185 on, Nov 17th, 2022
[ 12:00 AM ] - United States, WOPRAI
Simeon Gutman Maintained (TGT) at Hold with Decreased Target to $155 on, Nov 17th, 2022
[ 12:00 AM ] - United States, WOPRAI
Kate McShane Maintained (TGT) at Strong Buy with Decreased Target to $175 on, Nov 17th, 2022
[ 12:00 AM ] - United States, WOPRAI
Scot Ciccarelli Maintained (TGT) at Hold with Decreased Target to $151 on, Nov 17th, 2022
[ 12:00 AM ] - United States, WOPRAI
David Risinger Maintained (TBPH) at Buy with Increased Target to $14 on, Nov 17th, 2022

David Risinger Maintained (TBPH) at Buy with Increased Target to $14 on, Nov 17th, 2022


Published on 2024-10-28 00:14:17 - WOPRAI, David Risinger
  Print publication without navigation


David Risinger of SVB Leerink, Maintained "Theravance Biopharma, Inc." (TBPH) at Buy with Increased Target from $12 to $14 on, Nov 17th, 2022.

David has made no other calls on TBPH in the last 4 months.



There are 2 other peers that have a rating on TBPH. Out of the 2 peers that are also analyzing TBPH, 0 agree with David's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with David

  • Douglas Tsao of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $19 on, Tuesday, November 8th, 2022
  • Vikram Purohit of "Morgan Stanley" Maintained at Sell with Decreased Target to $10 on, Monday, July 25th, 2022

Contributing Sources